SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-22
👔
OMEROS CORP
@OMER_InsiderForm 4 Filing: Demopulos Peter A MD Acquires (Grant) shares of $OMER
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
OMEROS CORP
Ticker: $OMER
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-18
Shares: 15,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Demopulos Peter A MD, holds the title of Director at OMEROS CORP.
On 2026-06-18, the insider transacted 15,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Demopulos Peter A MD (Director) was granted $0 of $OMER
Post-Transaction Position: 15,000 shares
SEC Accession No: 0001437749-26-021236 (CIK: 1472161)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.